Nueve pacientes de cáncer de riñón reciben una vacuna personalizada que les mantiene libres de enfermedad durante más de tres años

Nine kidney cancer patients have remained disease-free for more than three years after receiving a personalized vaccine. The treatment successfully triggered targeted immune responses directed specifically against the mutations found in the patients' tumors.